Adalimumab in the treatment of pediatric Behçet’s disease: case-based review

Phenotypes in Behçet’s syndrome

(2019) Emire Seyahi   Internal and Emergency Medicine

Biologics for the treatment of Juvenile Idiopathic Arthritis

(2018) Dimitri Poddighe et al.   CURRENT MEDICINAL CHEMISTRY

The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies

(2018) Iris Deitch et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

(2018) José Luis Martín-Varillas et al.   OPHTHALMOLOGY

Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study

(2018) Belén Atienza-Mateo et al.   RHEUMATOLOGY

Vascular Behçet’s syndrome: an update

(2018) Giacomo Emmi et al.   Internal and Emergency Medicine

A national cohort study on pediatric Behçet’s disease: cross-sectional data from an Italian registry

(2017) Romina Gallizzi et al.   Pediatric Rheumatology

Paediatric Behçet’s disease: a UK tertiary centre experience

(2016) Sira Nanthapisal et al.   CLINICAL RHEUMATOLOGY

Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study

(2016) Antonio Vitale et al.   CLINICAL RHEUMATOLOGY

Behçet’s disease in children, an overview

(2016) Isabelle Koné-Paut   Pediatric Rheumatology

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network

(2016) Hélène Vallet et al.   Arthritis & Rheumatology

Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD

(2015) Isabelle Koné-Paut et al.   ANNALS OF THE RHEUMATIC DISEASES

Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease

(2015) Satoshi Tanida et al.   Clinical Gastroenterology and Hepatology

Successful treatment with canakinumab of a paediatric patient with resistant Behçet’s disease

(2015) Ilaria Pagnini et al.   RHEUMATOLOGY

A hyper-ferritinemia syndrome evolving in recurrent macrophage activation syndrome, as an onset of amyopathic juvenile dermatomyositis: A challenging clinical case in light of the current diagnostic criteria

(2014) Dimitri Poddighe et al.   AUTOIMMUNITY REVIEWS

Biological Treatments in Behçet’s Disease: Beyond Anti-TNF Therapy

(2014) Francesco Caso et al.   MEDIATORS OF INFLAMMATION

Anti-TNF-  therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

(2014) V. Calvo-Rio et al.   RHEUMATOLOGY

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis

(2013) Gabriele Simonini et al.   Pediatric Rheumatology

Behçet Syndrome: Is It One Condition?

(2012) H. Yazici et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors

(2011) Armen Yuri Gasparyan et al.   RHEUMATOLOGY INTERNATIONAL

Pediatric Neuro-Behçet's Disease Responsive to Adalimumab

(2010) Angela Byun Robinson et al.   PEDIATRIC NEUROLOGY

EULAR recommendations for the management of Behcet disease

(2008) G Hatemi et al.   ANNALS OF THE RHEUMATIC DISEASES

Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study

(2007) Yelda Karincaoglu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY